Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS

Author(s)

• 

  Samantha Armstrong, MD

  Assistant Professor of Hematology/Oncology
  Indiana University Melvin and Bren Simon Cancer Center
  Indianapolis, Indiana, United States

  Slides PDF

Co-Author(s)

• LB

  Lauren Blackwell, PharmD

  Indiana University Melvin and Bren Simon Cancer Center
  Indianapolis, Indiana, United States
• 

  Korbin Davis, MD

  Radiology Fellow
  Indiana University Melvin and Bren Simon Cancer Center
  Indianapolis, Indiana, United States
• JC

  Jason Childress, MD

  Indiana University Melvin and Bren Simon Cancer Center
  Indianapolis, Indiana, United States
• TS

  Taylor Stethen, MD

  Indiana University Melvin and Bren Simon Cancer Center
  Indianapolis, Indiana, United States
• PN

  Paul Niziolek, MD

  Indiana University Melvin and Bren Simon Cancer Center
  Indianapolis, Indiana, United States
• MT

  Mark Tann, MD

  Indiana University Melvin and Bren Simon Cancer Center
  Indianapolis, Indiana, United States
• SS

  Sarah Spargo, PharmD

  Clinical Oncology Pharmacist
  Indiana University Melvin and Bren Simon Cancer Center
  Indianapolis, Indiana, United States
• PK

  Pauline Kim, PharmD

  Oncology Pharmacist
  Indiana University Melvin and Bren Simon Cancer Center
  Indianapolis, Indiana, United States
• 

  Allie Carter, MS

  Biostatistician
  Indiana University Department of Biostatistics and Health Data Science
  Indianapolis, Indiana, United States
• LW

  Lawrence Wurtz, MD

  Indiana University Melvin and Bren Simon Cancer Center
  Indianapolis, Indiana, United States
• CC

  Christopher Collier, MD

  Assistant Professor
  Indiana University Melvin and Bren Simon Cancer Center
  Indianapolis, Indiana, United States
• AR

  Anna Roshal, MD

  Indiana University Melvin and Bren Simon Cancer Center
  Indianapolis, Indiana, United States
• 

  Susan Perkins, PhD

  Professor
  Indiana University Department of Biostatistics and Health Data Science
  Indianapolis, Indiana, United States
• 

  Daniel Rushing, MD (he/him/his)

  Professor of Clinical Medicine
  Indiana University Melvin and Bren Simon Cancer Center
  Indianapolis, Indiana, United States